Insight Molecular Diagnostics (IMDX) Other Non Operating Income (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Other Non Operating Income of $146000.0 for Q1 2026, down 71.15% sequentially from $506000.0 in Q4 2025, and down 7.01% YoY from $157000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Other Non Operating Income (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Other Non Operating Income data on file, last reported at $146000.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 7.01% year-over-year to $146000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 114.59% YoY) and the FY2025 annual result came in at $1.0 million, up 118.83% from the prior year.
- Other Non Operating Income fell to $146000.0 in Q1 2026 per IMDX's latest filing, from $506000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $506000.0 in Q4 2025, with the low at -$371000.0 in Q4 2022.
- Average Other Non Operating Income over 5 years is $114470.6, with a median of $127000.0 recorded in 2023.
- Year-over-year, Other Non Operating Income slumped 1900.0% in 2022 and soared 15400.0% in 2024.
- Insight Molecular Diagnostics' Other Non Operating Income stood at -$371000.0 in 2022, then soared by 172.51% to $269000.0 in 2023, then plunged by 45.72% to $146000.0 in 2024, then surged by 246.58% to $506000.0 in 2025, then plunged by 71.15% to $146000.0 in 2026.
- Business Quant data shows IMDX's Other Non Operating Income at $146000.0 in Q1 2026, $506000.0 in Q4 2025, and $223000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146,000.00 |
| Dec 31, 2025 | 506,000.00 |
| Sep 30, 2025 | 223,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Mar 31, 2025 | 157,000.00 |
| Dec 31, 2024 | 146,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | 127,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -371,000.00 |
| Sep 30, 2022 | 62,000.00 |
| Jun 30, 2022 | 278,000.00 |
| Mar 31, 2022 | -36,000.00 |
| Dec 31, 2021 | -1.18 Mn |
| Sep 30, 2021 | -8,000.00 |
| Jun 30, 2021 | 16,000.00 |